About NanoHybrids
NanoHybrids develops nanoparticle contrast agents for Photoacoustics, Optical Imaging, Microscopy, Molecular Diagnostic and Theranostic applications.
As nanotechnology rapidly expands into the realms of medicine, there is an unmet need for “smart” nanoparticles capable of homing in on diseased tissue while leaving healthy cells intact. When targeted to specific biomarkers, these nanoparticles can provide critical information about the biology of the disease in the context of the anatomy both in vitro and in vivo.
Our nano-sized agents can enhance biomedical imaging techniques by interacting specifically with diseased cells and allowing for real time imaging of functional biology. Our products can potentially be employed in a wide variety of applications including optical biomedical imaging, microscopy, molecular diagnostics and theranostic approaches.
Our current line of specially designed gold nanoparticles for the research market presents several advantages over other commercially available nanoparticles including superior thermodynamic properties and higher signal strength.
Contact us at info@nanohybrids.net for more information about our company and products.
Our Customers
Our customers include scientists from premier research institutions across the world.
- MD Anderson Cancer Center
- Johns Hopkins
- Genentech / Roche
- Stanford
- Northwestern University
- Cal Tech
- Georgia Tech
- University of Texas Health Science Center
- Monash University
- Ryerson University
- University of Queensland
